ALS
Tel Aviv University study opens path to gene therapy for ALS
A new Israeli-led study identifies an RNA-based therapy that may halt ALS progression and regenerate nerve cells.
A-G's husband Zion Miara passes away after battling ALS
Brad Smith becomes first non-verbal ALS patient to narrate video using Neuralink brain chip
Hapoel Jerusalem partners with IsrALS
New research uncovers method to prevent DNA breakdown, aging - study
The research focuses on a protein called SIRT6, which seems to have remarkable properties.
Weizmann Institute researchers discover new Lou Gehrig’s disease neural pathway
The incurable neurological condition, which affects about one in 50,000 people, gradually paralyzes patients, halting the ability to speak, eat, move and even breathe.
Is ALS reversible? -TAU study
Researchers from Tel Aviv University identified the biological mechanism causing nerve destruction in the neurodegenerative disease ALS.
Promising stem-cell based drug for treatment of ALS receives patent
The therapeutic drug is safe for administration and helpful in slowing disease progression, as well as increasing life expectancy and the overall quality of life for ALS patients.
Hillel's Tech Corner: NeuroSense: What ALS patients deserve
NeuroSense Therapeutics is a clinical stage drug development company offering ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Israeli biotech firm's ALS treatment shows safety of use in trials
The objective of this trial was to evaluate the safety of their treatment, with a secondary objective of the trial of estimating its preliminary efficacy.
Investigational drug proven to prolong survival of ALS patients - study
The median overall survival for all CENTAUR study participants being administered AMX0035 was 6.5 months longer than the group originally randomized to placebo.
Israeli biotech firm's ALS treatment shows positive results in trials
"We are now focused on advancing strategic FDA regulatory processes that will necessitate the conduct of global multi-center clinical trials."
Israeli treatment could delay deadly effects of ALS – new study
AstroRx is a cell therapy product containing functional healthy astrocytes derived from human embryonic stem cells that aim to protect diseased motor neurons.
Rabbi suffering from ALS makes cross-country trip for son’s bar mitzvah
Rabbi Yitzi Hurwitz, 47, writes a weekly commentary on the Torah and a blog offering marriage advice.
